These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25821966)

  • 1. Effect of anti-ApoA-I antibody-coating of stents on neointima formation in a rabbit balloon-injury model.
    Strang AC; Knetsch ML; Koole LH; de Winter RJ; van der Wal AC; de Vries CJ; Tak PP; Bisoendial RJ; Stroes ES; Rotmans JI
    PLoS One; 2015; 10(3):e0122836. PubMed ID: 25821966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Novel Stent on Re-Endothelialization, Platelet Adhesion, and Neointimal Formation.
    Tang H; Wang Q; Wang X; Zhou J; Zhu M; Qiao T; Liu C; Mao C; Zhou M
    J Atheroscler Thromb; 2016; 23(1):67-80. PubMed ID: 26347048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation.
    Lim WH; Seo WW; Choe W; Kang CK; Park J; Cho HJ; Kyeong S; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2798-805. PubMed ID: 22015656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents.
    Tang C; Wang G; Wu X; Li Z; Shen Y; Lee JC; Yu Q
    J Vasc Surg; 2011 Feb; 53(2):461-71. PubMed ID: 21129910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation while Enhancing Strut Coverage in Rabbits.
    Ruiter MS; van Tiel CM; Doornbos A; Marinković G; Strang AC; Attevelt NJ; de Waard V; de Winter RJ; Steendam R; de Vries CJ
    PLoS One; 2015; 10(9):e0138459. PubMed ID: 26389595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
    Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
    Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor.
    Ma X; Hibbert B; Dhaliwal B; Seibert T; Chen YX; Zhao X; O'Brien ER
    Cardiovasc Res; 2010 May; 86(2):338-45. PubMed ID: 20167573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of parallel micro-engineered stent grooves on endothelial cell migration, proliferation, and function: an in vivo correlation study of the healing response in the coronary swine model.
    Sprague EA; Tio F; Ahmed SH; Granada JF; Bailey SR
    Circ Cardiovasc Interv; 2012 Aug; 5(4):499-507. PubMed ID: 22763346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
    Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of endothelialization and neointimal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin.
    Lee JM; Choe W; Kim BK; Seo WW; Lim WH; Kang CK; Kyeong S; Eom KD; Cho HJ; Kim YC; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
    Biomaterials; 2012 Dec; 33(35):8917-27. PubMed ID: 22981075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inorganic coatings for cardiovascular stents: In vitro and in vivo studies.
    Mikhalovska L; Chorna N; Lazarenko O; Haworth P; Sudre A; Mikhalovsky S
    J Biomed Mater Res B Appl Biomater; 2011 Feb; 96(2):333-41. PubMed ID: 21210514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
    van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxybutyl Chitosan Polymer-Mediated CD133 Antibody Coating of Metallic Stents to Reduce Restenosis in a Porcine Model of Atherosclerosis.
    Li J; Zhang Q; Li D; An Y; Kutryk MB
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):322-9. PubMed ID: 25412893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis.
    Ribichini F; Joner M; Ferrero V; Finn AV; Crimins J; Nakazawa G; Acampado E; Kolodgie FD; Vassanelli C; Virmani R
    J Am Coll Cardiol; 2007 Jul; 50(2):176-85. PubMed ID: 17616304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits.
    Wieneke H; Dirsch O; Sawitowski T; Gu YL; Brauer H; Dahmen U; Fischer A; Wnendt S; Erbel R
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):399-407. PubMed ID: 14571494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo biocompatibility of a plasma-activated, coronary stent coating.
    Waterhouse A; Wise SG; Yin Y; Wu B; James B; Zreiqat H; McKenzie DR; Bao S; Weiss AS; Ng MK; Bilek MM
    Biomaterials; 2012 Nov; 33(32):7984-92. PubMed ID: 22889486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelialization and in-stent restenosis on the surface of glycoprotein IIIa monoclonal antibody eluting stent.
    Yin TY; Wang GX; Zhang DC; Du DY; Li ZG; Luo LL; Hou YB; Wang YZ; Zhao JB
    J Biomed Mater Res A; 2012 Jun; 100(6):1398-406. PubMed ID: 22374816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents.
    Prasad CK; Resmi KR; Krishnan LK; Vaishnav R
    J Biomater Appl; 2005 Apr; 19(4):271-86. PubMed ID: 15788425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model.
    Sedaghat A; Sinning JM; Paul K; Kirfel G; Nickenig G; Werner N
    Clin Res Cardiol; 2013 Jun; 102(6):413-25. PubMed ID: 23397592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.